This NDC is on FDA's drug shortage list (posted Jul 26, 2023)

Reported reason: Demand increase for the drug

Product Information

METHYLPHENIDATE ER 72 MG TAB is a generic product labeled by Trigen Laboratories, LLC, priced at $16.0891 per EA under NDC 13811071030. Its NADAC has been published 361 times since Dec 18, 2019.

FDA first approved this application on Jul 28, 2017. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

METHYLPHENIDATE ER 72 MG TAB

Methylphenidate hydrochloride
$16.0891per EA
DEA Schedule CII

Strength

72 mg/1

NDC

13811071030

Classification

Generic

Dosage Form

TABLET, EXTENDED RELEASE

Route

ORAL

Effective Date

10/21/2026

Approval Type

Generic (ANDA)

FDA Application

ANDA205327

FDA Approved

7/28/2017

TE Code

AB

On Market Since

12/29/2017

Pharmacological Classes

Central Nervous System Stimulant
Central Nervous System Stimulation

Price Statistics

The NADAC for METHYLPHENIDATE ER 72 MG TAB has been published 361 times since Dec 18, 2019, and over the history we have for it it has declined 3.6%. The table below summarizes its recorded NADAC range and movement.

Current price$16.0891 per EA
All-time high$19.0565 (Apr 10, 2024)
All-time low$12.9747 (Nov 20, 2024)
52-week high$16.7359
52-week low$16.0891
Median price$16.2675
Average price$16.2232
Largest weekly change-22.1% (Apr 17, 2024)
Weeks tracked361
Tracking sinceDec 18, 2019

Price History

1W

0.0%

1M

-2.5%

3M

-3.8%

6M

-2.6%

1Y

-0.8%

3Y

-5.4%

5Y

-13.8%

All

-3.6%

Generic Alternatives

The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Continue researching this drug

Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.

Frequently asked questions

What is the NADAC price of METHYLPHENIDATE ER 72 MG TAB?

The current National Average Drug Acquisition Cost (NADAC) for METHYLPHENIDATE ER 72 MG TAB, manufactured by Trigen Laboratories, LLC, is $16.0891 per EA (NDC 13811071030), effective Nov 11, 2026.

How has the price of METHYLPHENIDATE ER 72 MG TAB changed over time?

Over the history we have for it, the NADAC for METHYLPHENIDATE ER 72 MG TAB has declined 3.6%. It has been tracked across 361 weekly CMS publications since Dec 18, 2019.

What are the highest and lowest recorded NADAC prices for METHYLPHENIDATE ER 72 MG TAB?

Since Dec 18, 2019, the NADAC for METHYLPHENIDATE ER 72 MG TAB has ranged from a low of $12.9747 (Nov 20, 2024) to a high of $19.0565 (Apr 10, 2024), with a median of $16.2675 per EA.

Are there cheaper alternatives to METHYLPHENIDATE ER 72 MG TAB?

1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength as METHYLPHENIDATE ER 72 MG TAB in a comparable dosage form, but none are currently priced below it.

Who manufactures METHYLPHENIDATE ER 72 MG TAB?

METHYLPHENIDATE ER 72 MG TAB (NDC 13811071030) is labeled by Trigen Laboratories, LLC, and CMS classifies it as a generic product.

Is METHYLPHENIDATE ER 72 MG TAB in shortage?

Yes — NDC 13811071030 is currently listed in FDA's drug shortage database (posted Jul 26, 2023). Reported reason: Demand increase for the drug.